For semaglutide, 25.9% doubled their weight loss, 15.6% had some additional weight loss, and 14.6% maintained their initial loss, totaling 56.1% in the sustained or improved categories
Up to total of $10,000 worth of specialist services
Results for participants who received placebo are not reported as this subgroup was small (n = 4)
GLP-1 drugs seem to fight addiction by reducing the hormone dopamine in a brain system involved in reward, motivation and stress a system "that is co-opted or hijacked, if you will, by addiction," Al-Aly says
~ AlphaMD Clomid (clomiphene citrate) is a medication traditionally prescribed for female fertility issues, but it's also widely used in men and women to treat hormone imbalances, particularly in the context of testosterone deficiency or hypogonadism
Only when Eli Lilly began testing dual GLP-1/GIP agonists did the picture change dramatically